Supplementary applicant guidance: clinical test development and validation

Additional guidance to support applicants preparing an application to MRC Developmental Pathway Funding Scheme for biomarker development and validation.

Medical Research Council (MRC)


DPFS applicant guidance: clinical test development and validation (PDF)

, 61 KB

If you cannot open or read this document, you can ask for a different format.

Request a different format

Email, telling us:

  • the name of the document
  • what format you need
  • any assistive technology you use (such as type of screen reader).

Find out about our approach to the accessibility of our website.


In May 2022, MRC conducted a portfolio analysis of applications to the Developmental Pathway Funding Scheme (DPFS) and the associated panel feedback to applicants following review of their proposals. The analysis identified opportunities for applicants to enhance the competitiveness of their DPFS applications across several common challenge areas.

Following consultation with the DPFS panel and other expert stakeholders, this supplementary guidance speaks to these challenge areas and provides additional guidance for applicants applying to DPFS for funding to develop and validate clinical tests.

This is the website for UKRI: our seven research councils, Research England and Innovate UK. Let us know if you have feedback or would like to help improve our online products and services.